insights_auto
Why is ABCL down 4.57%?
Dive Deeperchevron_right
ABCL:NASDAQ
AbCellera Biologics Inc
$13.15
arrow_downward
-4.57%(-0.63) 1D
$13.27
arrow_upward
+0.92% (+0.12)bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABCL...
Open
$14.00
High
$14.53
Low
$12.93
Mkt. cap
4.25B
Avg. vol.
4.98M
Volume
9.79M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
Open
$14.00
High
$14.53
Low
$12.93
Mkt. cap
4.25B
Avg. vol.
4.98M
Volume
9.79M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
News stories
From web sources and news partners
TipRanks
·
11 hours ago
Why AbCellera’s Hot Stock Is Suddenly Sinking
https://www.dars.gov.et/
·
1 month ago
ABCL Q2 2026 Earnings: Wider-than-Expected Loss Weighs on Shares - SaaS Earnings Trends
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com